ENTITY
Sino Biopharmaceutical

Sino Biopharmaceutical (1177 HK)

199
Analysis
Health CareHong Kong
Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.
more
Exchange Announcement16 Jan 2025 17:28
Exchange Announcement14 Jan 2025 17:43
Exchange Announcement13 Jan 2025 16:31
x